On the 11^th of March I bought shares in AbbVie (ABBV) at a price of USD 56.50 and a yield of 3.6%. At this price, Abbvie fulfilled five of seven of my investment criteria that I follow to build up financial independence. Find a detailed analysis here (PDF file).

Continue reading →